aher.dev

Unofficial and not affiliated with Duke. A snapshot of classes that were open on 22 Oct 2026. Seats change daily, so confirm in DukeHub before you plan around anything.

Courses / Fuqua / HLTHMGMT

HLTHMGMT 717

Biotechnology and Pharmaceutical Strategy

David Blaine RidleyNotable faculty

Co-proposed the FDA priority review voucher in Health Affairs (2006); Congress created the program in 2007. Source

Why it's on my list

David Ridley co-proposed the FDA priority review voucher in 2006. Congress enacted it the next year.

My note, not Duke's.

Description from DukeHub

This course examines a number of economic issues relating to innovation, competition, and regulation in the pharmaceutical industry and their role in management decision making. We concentrate on factors that distinguish pharmaceuticals from other industries such as its strong research intensity, broader ties to the health care system, and the critical role of government regulations and policy. The overall perspective is international, but the emphasis is on current market and policy developments in the United States. This course is for Daytime MBA and Accelerated Daytime MBA students.

Skills

AI-resilient: 1 of 5

  • No: Physical, lab or field work
  • No: Live work with people
  • Yes: Judgment someone is accountable for · "strategy"
  • No: A craft you practice with your hands or body
  • No: Small, in-person format

The checks lean on Microsoft Research, Working with AI (2025), which found generative AI applies least to physical work and hands-on work with people. A signal, not a promise. How the score works

More in HLTHMGMT

All HLTHMGMT courses · All of Fuqua